Kewaunee Scienti Financials
Kewaunee Scienti (KEQU) reported $282.0M in revenue for fiscal year 2026, up 17.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Sales growth is converting to cash, but margin compression and financing demands are limiting how much reaches net profit.
From FY2024 to FY2026, gross margin stayed broadly stable, yet operating margin fell from9.0% to5.9% ; the squeeze is occurring below gross profit, suggesting overhead or other operating costs absorbed the benefit of sales growth. FY2026 operating cash flow was nearly twice net income, and free cash flow remained positive at$14.7M ; earnings are therefore supported by cash generation after reinvestment, not just accounting profit.
Revenue expanded
Debt-to-equity fell from 1.4x in FY2024 to 0.2x in FY2026, a pronounced shift toward a less leveraged balance-sheet posture. Yet cash declined from
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Kewaunee Scienti's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Kewaunee Scienti has an operating margin of 5.9%, meaning the company retains $6 of operating profit per $100 of revenue. This results in a moderate score of 55/100, indicating healthy but not exceptional operating efficiency. This is down from 7.4% the prior year.
Kewaunee Scienti's revenue surged 17.3% year-over-year to $282.0M, reflecting rapid business expansion. This strong growth earns a score of 79/100.
Kewaunee Scienti carries a low D/E ratio of 0.20, meaning only $0.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 73/100, indicating a strong balance sheet with room for future borrowing.
Kewaunee Scienti's current ratio of 2.18 indicates adequate short-term liquidity, earning a score of 62/100. The company can meet its near-term obligations, though with limited headroom.
Kewaunee Scienti has a free cash flow margin of 5.2%, earning a moderate score of 51/100. The company generates positive cash flow after capital investments, but with room for improvement.
Kewaunee Scienti earns a strong 12.9% return on equity (ROE), meaning it generates $13 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 68/100. This is down from 17.7% the prior year.
Kewaunee Scienti scores 3.44, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Kewaunee Scienti passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Kewaunee Scienti generates $1.94 in operating cash flow ($18.6M OCF vs $9.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Kewaunee Scienti earns $4.33 in operating income for every $1 of interest expense ($16.7M vs $3.9M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Kewaunee Scienti generated $282.0M in revenue in fiscal year 2026. This represents an increase of 17.3% from the prior year.
Kewaunee Scienti's EBITDA was $23.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 2.1% from the prior year.
Kewaunee Scienti reported $9.6M in net income in fiscal year 2026. This represents a decrease of 15.7% from the prior year.
Kewaunee Scienti earned $3.22 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 15.9% from the prior year.
Cash & Balance Sheet
Kewaunee Scienti generated $14.7M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 16.5% from the prior year.
Kewaunee Scienti held $9.9M in cash against $15.1M in long-term debt as of fiscal year 2026.
Not reported for fiscal year 2026.
Margins & Returns
Kewaunee Scienti's gross margin was 28.5% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.1 percentage points from the prior year.
Kewaunee Scienti's operating margin was 5.9% in fiscal year 2026, reflecting core business profitability. This is down 1.5 percentage points from the prior year.
Kewaunee Scienti's net profit margin was 3.4% in fiscal year 2026, showing the share of revenue converted to profit. This is down 1.3 percentage points from the prior year.
Kewaunee Scienti's ROE was 12.9% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 4.8 percentage points from the prior year.
Capital Allocation
Kewaunee Scienti invested $898K in research and development in fiscal year 2026. This represents a decrease of 2.3% from the prior year.
Kewaunee Scienti repurchased no shares in fiscal year 2026. This represents a decrease of 100.0% from the prior year.
Kewaunee Scienti invested $3.9M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 81.8% from the prior year.
KEQU Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $282.0M+17.3% | $240.5M+18.0% | $203.8M-7.2% | $219.5M+30.0% | $168.9M+14.5% | $147.5M0.0% | $147.5M+0.7% | $146.6M-7.3% | $158.1M+14.1% | $138.6M+7.7% | $128.6M+8.2% | $118.8M+6.9% | $111.2M-5.1% | $117.1M+13.9% | $102.8M |
| Cost of Revenue | $201.6M+17.4% | $171.6M+13.1% | $151.7M-17.5% | $183.9M+27.1% | $144.7M+17.1% | $123.5M-0.5% | $124.1M+2.4% | $121.2M-3.7% | $125.9M+12.5% | $112.0M+6.7% | $104.9M+8.1% | $97.1M+8.9% | $89.1M-6.0% | $94.9M+13.3% | $83.7M |
| Gross Profit | $80.4M+16.8% | $68.9M+32.3% | $52.1M+46.3% | $35.6M+46.9% | $24.2M+0.9% | $24.0M+2.4% | $23.4M-7.5% | $25.3M-21.3% | $32.2M+20.9% | $26.6M+12.2% | $23.7M+8.9% | $21.8M-1.2% | $22.0M-1.0% | $22.3M+16.2% | $19.2M |
| R&D Expenses | $898K-2.3% | $919K-0.1% | $920K-9.1% | $1.0M+2.2% | $990K-29.6% | $1.4M-22.6% | $1.8M+17.2% | $1.6M+0.8% | $1.5M+32.2% | $1.2M-0.3% | $1.2M+24.7% | $936K+11.2% | $842K-3.4% | $872K-7.3% | $941K |
| Operating Income | $16.7M-5.9% | $17.8M-2.9% | $18.3M+240.8% | $5.4M+305.7% | -$2.6M-98.2% | -$1.3M+43.9% | -$2.3M-211.0% | $2.1M-78.7% | $9.9M+51.6% | $6.5M+14.8% | $5.7M+9.0% | $5.2M-12.4% | $6.0M+13.0% | $5.3M+94.5% | $2.7M |
| Interest Expense | $3.9M+20.2% | $3.2M+78.7% | $1.8M+3.7% | $1.7M+174.4% | $632K+62.5% | $389K-21.1% | $493K+34.3% | $367K+22.7% | $299K+2.4% | $292K-4.6% | $306K-5.8% | $325K-12.9% | $373K+3.0% | $362K-18.7% | $445K |
| Income Tax | $3.3M+2.1% | $3.2M+153.9% | -$5.9M-289.2% | $3.1M-10.8% | $3.5M+255.4% | $990K-43.7% | $1.8M+294.2% | $446K-89.3% | $4.2M+95.7% | $2.1M+14.2% | $1.9M+6.7% | $1.7M-12.0% | $2.0M+28.8% | $1.5M+108.4% | $739K |
| Net Income | $9.6M-15.7% | $11.4M-39.2% | $18.8M+2441.1% | $738K+112.0% | -$6.1M-66.8% | -$3.7M+21.7% | -$4.7M-406.5% | $1.5M-71.0% | $5.3M+17.0% | $4.5M+18.8% | $3.8M+7.7% | $3.5M-9.4% | $3.9M+28.0% | $3.0M+195.2% | $1.0M |
| EPS (Diluted) | $3.22-15.9% | $3.83-40.0% | $6.38+2452.0% | $0.25+111.4% | -$2.20-65.4% | -$1.33+21.8% | -$1.70-409.1% | $0.55-71.1% | $1.90+14.5% | $1.66+16.9% | $1.42+6.8% | $1.33-10.1% | $1.48+26.5% | $1.17+192.5% | $0.40 |
Not reported in any period shown, so not listed: SG&A Expenses.
KEQU Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $178.3M-8.4% | $194.7M+44.4% | $134.8M+13.3% | $118.9M+0.1% | $118.8M+32.9% | $89.4M+6.5% | $83.9M-3.8% | $87.2M+2.5% | $85.1M+5.1% | $80.9M+11.8% | $72.4M+4.2% | $69.5M+10.8% | $62.7M-8.8% | $68.7M+8.5% | $63.4M |
| Current Assets | $105.4M-11.0% | $118.4M+22.3% | $96.8M+10.1% | $87.9M-4.0% | $91.6M+51.5% | $60.5M+11.5% | $54.2M-17.0% | $65.4M+1.5% | $64.4M+7.7% | $59.8M+17.4% | $51.0M+4.5% | $48.8M+12.5% | $43.4M-8.2% | $47.2M+10.3% | $42.8M |
| Cash & Equivalents | $9.9M-33.4% | $14.9M-35.8% | $23.3M+188.0% | $8.1M+82.2% | $4.4M-14.8% | $5.2M+19.3% | $4.4M-59.0% | $10.6M+9.6% | $9.7M-22.3% | $12.5M+139.5% | $5.2M+71.6% | $3.0M-51.3% | $6.2M+7.5% | $5.8M-6.1% | $6.2M |
| Inventory | $30.5M-7.1% | $32.8M+58.9% | $20.7M-5.5% | $21.9M-8.0% | $23.8M+44.1% | $16.5M+7.7% | $15.3M-10.9% | $17.2M-7.2% | $18.5M+24.2% | $14.9M-4.4% | $15.6M+22.6% | $12.7M+6.8% | $11.9M-9.6% | $13.2M+12.3% | $11.8M |
| Accounts Receivable | $58.7M-5.8% | $62.4M+38.4% | $45.1M-2.2% | $46.1M+11.7% | $41.3M+25.5% | $32.9M+17.2% | $28.1M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $12.5M0.0% | $12.5M | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $101.5M-21.0% | $128.4M+63.5% | $78.6M-2.3% | $80.4M-2.6% | $82.6M+72.4% | $47.9M+5.9% | $45.2M+14.4% | $39.5M+7.1% | $36.9M-2.0% | $37.7M+11.2% | $33.9M-1.3% | $34.3M+20.3% | $28.5M-18.7% | $35.0M+10.6% | $31.7M |
| Current Liabilities | $48.4M-10.0% | $53.7M+31.7% | $40.8M+1.8% | $40.1M-5.3% | $42.3M+23.7% | $34.2M+26.3% | $27.1M-17.3% | $32.7M+18.5% | $27.6M+2.6% | $26.9M+28.5% | $20.9M-0.5% | $21.1M+30.3% | $16.2M-26.9% | $22.1M+13.6% | $19.5M |
| Long-Term Debt | $15.1M-56.5% | $34.7M | N/A | N/A | N/A | N/A | $0-100.0% | $229K-81.9% | $1.3M-48.0% | $2.4M-27.4% | $3.3M-11.2% | $3.8M-10.0% | $4.2M+28.3% | $3.3M-5.8% | $3.5M |
| Total Equity | $74.7M+15.9% | $64.5M+17.7% | $54.8M+46.4% | $37.4M+4.8% | $35.7M-13.5% | $41.2M+7.4% | $38.4M-18.4% | $47.1M-1.3% | $47.7M+9.8% | $43.5M+13.6% | $38.2M+9.7% | $34.9M+2.7% | $34.0M+7.2% | $31.7M+7.3% | $29.5M |
| Retained Earnings | $68.5M+16.3% | $58.9M+24.0% | $47.5M+65.2% | $28.8M+2.6% | $28.0M-17.9% | $34.1M-9.7% | $37.8M-13.2% | $43.6M-0.6% | $43.8M+10.2% | $39.8M+8.0% | $36.8M+7.1% | $34.4M+7.2% | $32.1M+2.9% | $31.2M+6.8% | $29.2M |
KEQU Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $18.6M+26.0% | $14.8M-24.4% | $19.6M+616.2% | -$3.8M+51.9% | -$7.9M-964.6% | $912K-78.1% | $4.2M+67.1% | $2.5M-21.8% | $3.2M-72.7% | $11.7M+60.4% | $7.3M+217.4% | $2.3M-71.6% | $8.1M+110.8% | $3.8M-44.7% | $6.9M |
| Capital Expenditures | $3.9M+81.8% | $2.2M-50.5% | $4.4M+5.4% | $4.1M+117.4% | $1.9M-20.4% | $2.4M-2.8% | $2.5M-41.5% | $4.2M+24.1% | $3.4M+30.0% | $2.6M+19.4% | $2.2M-14.8% | $2.6M+27.1% | $2.0M-16.0% | $2.4M+67.6% | $1.4M |
| Free Cash Flow | $14.7M+16.5% | $12.6M-16.9% | $15.2M+291.4% | -$7.9M+18.9% | -$9.8M-559.5% | -$1.5M-187.6% | $1.7M+198.4% | -$1.7M-712.7% | -$212K-102.3% | $9.1M+78.0% | $5.1M+1935.4% | -$277K-104.6% | $6.0M+325.3% | $1.4M-74.1% | $5.5M |
| Investing Cash Flow | -$3.9M+87.3% | -$30.9M-606.6% | -$4.4M-5.4% | -$4.1M-117.4% | -$1.9M+20.4% | -$2.4M+2.8% | -$2.5M+41.5% | -$4.2M-24.1% | -$3.4M-37.0% | -$2.5M-67.7% | -$1.5M | N/A | N/A | -$2.4M-50.8% | -$1.6M |
| Financing Cash Flow | -$19.3M-360.8% | $7.4M+345.9% | -$3.0M-120.2% | $14.9M+35.4% | $11.0M+456.6% | $2.0M+126.6% | -$7.5M-419.5% | $2.3M+194.0% | -$2.5M-19.2% | -$2.1M+38.8% | -$3.4M | N/A | N/A | -$1.7M-58.2% | -$1.1M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $1.0M-48.6% | $2.0M+13.2% | $1.8M+14.3% | $1.6M+15.4% | $1.4M+10.3% | $1.2M+10.0% | $1.1M+8.4% | $1.0M+0.4% | $1.0M |
| Share Buybacks | $0-100.0% | $1.6M-20.1% | $2.0M | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
KEQU Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.5%-0.1pp | 28.6%+3.1pp | 25.6%+9.3pp | 16.2%+1.9pp | 14.3%-1.9pp | 16.3%+0.4pp | 15.9%-1.4pp | 17.3%-3.1pp | 20.3%+1.1pp | 19.2%+0.8pp | 18.4%+0.1pp | 18.3%-1.5pp | 19.8%+0.8pp | 19.0%+0.4pp | 18.6% |
| Operating Margin | 5.9%-1.5pp | 7.4%-1.6pp | 9.0%+6.5pp | 2.4%+4.0pp | -1.5%-0.7pp | -0.9%+0.7pp | -1.6%-3.0pp | 1.4%-4.8pp | 6.3%+1.6pp | 4.7%+0.3pp | 4.4%0.0pp | 4.4%-1.0pp | 5.4%+0.9pp | 4.5%+1.9pp | 2.6% |
| Net Margin | 3.4%-1.3pp | 4.7%-4.5pp | 9.2%+8.9pp | 0.3%+4.0pp | -3.6%-1.1pp | -2.5%+0.7pp | -3.2%-4.2pp | 1.0%-2.3pp | 3.3%+0.1pp | 3.3%+0.3pp | 3.0%0.0pp | 3.0%-0.5pp | 3.5%+0.9pp | 2.6%+1.6pp | 1.0% |
| Return on Equity | 12.9%-4.8pp | 17.7%-16.6pp | 34.3%+32.3pp | 2.0%+19.1pp | -17.2%-8.3pp | -8.9%+3.3pp | -12.2%-15.4pp | 3.3%-7.8pp | 11.1%+0.7pp | 10.4%+0.5pp | 9.9%-0.2pp | 10.1%-1.3pp | 11.5%+1.9pp | 9.6%+6.1pp | 3.5% |
| Return on Assets | 5.4%-0.5pp | 5.9%-8.1pp | 13.9%+13.3pp | 0.6%+5.8pp | -5.2%-1.1pp | -4.1%+1.5pp | -5.6%-7.3pp | 1.8%-4.5pp | 6.2%+0.6pp | 5.6%+0.3pp | 5.3%+0.2pp | 5.1%-1.1pp | 6.2%+1.8pp | 4.4%+2.8pp | 1.6% |
| Current Ratio | 2.180.0x | 2.20-0.2x | 2.37+0.2x | 2.200.0x | 2.17+0.4x | 1.77-0.2x | 2.000.0x | 2.00-0.3x | 2.33+0.1x | 2.22-0.2x | 2.43+0.1x | 2.32-0.4x | 2.68+0.5x | 2.14-0.1x | 2.20 |
| Debt-to-Equity | 0.20-0.3x | 0.54-0.9x | 1.43-0.7x | 2.15-0.2x | 2.31+1.2x | 1.16+1.2x | 0.000.0x | 0.000.0x | 0.030.0x | 0.060.0x | 0.090.0x | 0.110.0x | 0.120.0x | 0.100.0x | 0.12 |
| FCF Margin | 5.2%0.0pp | 5.3%-2.2pp | 7.5%+11.1pp | -3.6%+2.2pp | -5.8%-4.8pp | -1.0%-2.2pp | 1.1%+2.3pp | -1.2%-1.0pp | -0.1%-6.7pp | 6.5%+2.6pp | 4.0%+4.2pp | -0.2%-5.7pp | 5.4%+4.2pp | 1.2%-4.1pp | 5.3% |
Similar Companies
Where Kewaunee Scienti Ranks
Frequently Asked Questions
What is Kewaunee Scienti's annual revenue?
Kewaunee Scienti (KEQU) reported $282.0M in total revenue for fiscal year 2026. This represents a 17.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Kewaunee Scienti's revenue growing?
Kewaunee Scienti (KEQU) revenue grew by 17.3% year-over-year, from $240.5M to $282.0M in fiscal year 2026.
Is Kewaunee Scienti profitable?
Yes, Kewaunee Scienti (KEQU) reported a net income of $9.6M in fiscal year 2026, with a net profit margin of 3.4%.
What is Kewaunee Scienti's EBITDA?
Kewaunee Scienti (KEQU) had EBITDA of $23.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Kewaunee Scienti have?
As of fiscal year 2026, Kewaunee Scienti (KEQU) had $9.9M in cash and equivalents against $15.1M in long-term debt.
What is Kewaunee Scienti's gross margin?
Kewaunee Scienti (KEQU) had a gross margin of 28.5% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Kewaunee Scienti's operating margin?
Kewaunee Scienti (KEQU) had an operating margin of 5.9% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Kewaunee Scienti's net profit margin?
Kewaunee Scienti (KEQU) had a net profit margin of 3.4% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Kewaunee Scienti's return on equity (ROE)?
Kewaunee Scienti (KEQU) has a return on equity of 12.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Kewaunee Scienti's free cash flow?
Kewaunee Scienti (KEQU) generated $14.7M in free cash flow during fiscal year 2026. This represents a 16.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Kewaunee Scienti's operating cash flow?
Kewaunee Scienti (KEQU) generated $18.6M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Kewaunee Scienti's total assets?
Kewaunee Scienti (KEQU) had $178.3M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Kewaunee Scienti's capital expenditures?
Kewaunee Scienti (KEQU) invested $3.9M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Kewaunee Scienti spend on research and development?
Kewaunee Scienti (KEQU) invested $898K in research and development during fiscal year 2026.
What is Kewaunee Scienti's current ratio?
Kewaunee Scienti (KEQU) had a current ratio of 2.18 as of fiscal year 2026, which is generally considered healthy.
What is Kewaunee Scienti's debt-to-equity ratio?
Kewaunee Scienti (KEQU) had a debt-to-equity ratio of 0.20 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Kewaunee Scienti's return on assets (ROA)?
Kewaunee Scienti (KEQU) had a return on assets of 5.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Kewaunee Scienti's Altman Z-Score?
Kewaunee Scienti (KEQU) has an Altman Z-Score of 3.44, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Kewaunee Scienti's Piotroski F-Score?
Kewaunee Scienti (KEQU) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Kewaunee Scienti's earnings high quality?
Kewaunee Scienti (KEQU) has an earnings quality ratio of 1.94x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Kewaunee Scienti cover its interest payments?
Kewaunee Scienti (KEQU) has an interest coverage ratio of 4.33x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Kewaunee Scienti?
Kewaunee Scienti (KEQU) scores 65 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.